Sök

Dina träffar

Visar 10 av 46 träffar

In April 2023, the European Commission adopted regulatory proposals introducing a Unitary Supplementary Protection Certificate (SPC) and a centralised assessment procedure for SPCs for medicinal products. This study analyses the potential impacts of these proposals on access to medicines, the administrative burden to applicants and the cost to national health systems. This document was prepared by Policy Department for Citizens' Rights and Constitutional Affairs at the request of the JURI Committee ...

Most rare diseases are incurable. Research into new diagnostics and therapies is hampered by the low number of patients, limited amount of data, lack of multi-centre coordination and low profitability. Biosensors are a technology that, driven by continuous advances in artificial intelligence, can help disease detection, lower the cost of novel therapies, replace placebo groups in clinical trials and foster patient-centred, personalised (e)-medicine. Governance of biosensor technology involves targeted ...

In recent years, the use of artificial intelligence (AI) in medicine and healthcare has been praised for the great promise it offers, but has also been at the centre of heated controversy. This study offers an overview of how AI can benefit future healthcare, in particular increasing the efficiency of clinicians, improving medical diagnosis and treatment, and optimising the allocation of human and technical resources. The report identifies and clarifies the main clinical, social and ethical risks ...

Reinforced role for European Medicines Agency

Kort sammanfattning 13-01-2022

As part of building a European Health Union, as well as in response to the Covid 19 pandemic, the European Commission proposed in November 2020 to reinforce the European Medicines Agency's role in crisis preparedness and the management of medicines and medical devices. The proposed regulation seeks to better anticipate possible shortages and to ensure timely development of high-quality medicinal solutions, to allow the EU to react to health crises more quickly, efficiently, and in a coordinated manner ...

The European Commission has proposed a regulation on health technology assessment (HTA). HTA is a research-based tool that supports decision-making in healthcare by assessing the added value of a given health technology compared to others. The proposal would provide the basis for permanent EU-level cooperation in four areas. Member States would still be responsible for assessing the non-clinical (economic, ethical, social, etc.) aspects of health technology, and for pricing and reimbursement. While ...

EU cooperation on health technology assessment

Kort sammanfattning 08-12-2021

During the December plenary session, the European Parliament is expected to vote at second reading on a European Commission proposal to strengthen EU-level cooperation among Member States on assessing health technologies. Improved cooperation would profit national health systems and producers of medicines and medical devices, as approval procedures would be simplified, while also benefiting patients thanks to innovative, safe and effective health technologies becoming available more quickly.

Sequencing and analysis of the human genome – all the genetic information stored in our DNA – provide us with understanding about a person's ancestry, health and other traits. Thanks to DNA sequencing, medicine and the life sciences are able to predict and cure diseases. As DNA sequencing technologies continuously improve and become less costly, what if we all soon possessed our personal, smart DNA sequencers and apps to analyse our DNA?

This At A Glance summarises the key findings of the original study, which assesses the impact of the COVID-19 crisis on the Internal Market and consumer protection, including the impact of measures introduced at national and EU level to mitigate the consequences of the pandemic. What further measures should be considered in order to reinforce the resilience of the EU's Internal Market in the face of future crises? This document was provided by the Policy Department for Economic, Scientific and Quality ...

Thermal imaging cameras are currently being installed in office buildings, hospitals, shopping malls, schools and airports as a means of detecting people with fever-like symptoms. Given that these cameras are not necessarily designed to operate as medical devices, there are questions about their suitability in the context of the current pandemic. This note provides an overview of the use of thermal imaging empowered with artificial intelligence (AI) capabilities, its suitability in the context of ...